Science & Research Staff Directory
CAMH is a leader in mental health research, with more than 120 scientists at the core of our research enterprise.
Meet Our Scientists
Dr. Norman Giesbrecht
Scientist Emeritus, Institute for Mental Health Policy Research, CAMH
norman.giesbrecht@camh.ca About Dr. Norman Giesbrecht
Dr. Benjamin Goldstein
Clinician Scientist; Director, Centre for Youth Bipolar Disorder, Campbell Family Mental Health Research Institute, CAMH
benjamin.goldstein@camh.ca About Dr. Benjamin Goldstein
Dr. Vanessa Gonçalves
Independent Scientist, Brain Sciences Department, Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, CAMH
Vanessa.Goncalves@camh.ca About Dr. Vanessa Gonçalves
Dr. Ariel Graff
Head, Multimodal Imaging Group, Schizophrenia and Geriatrics, CAMH
ariel.graff@camh.ca About Dr. Ariel GraffDr. Kathryn Graham
Scientist Emeritus, Institute for Mental Health Policy Research, CAMH
kgraham@uwo.ca About Dr. Kathryn Graham
Dr. John Griffiths
Independent Scientist at the Krembil Centre for Neuroinformatics at CAMH, CAMH
About Dr. John GriffithsDr. Michael Grossman
Clinician Investigator, Campbell Family Mental Health Research Institute, CAMH
michael.grossman@camh.ca About Dr. Michael Grossman
Dr. Margaret Hahn
Clinician Scientist, Schizophrenia Division, CAMH
margaret.hahn@camh.ca About Dr. Margaret Hahn
Dr. John D. Haltigan
Independent Scientist, Child and Youth Psychiatry and Cundill Scholar, CAMH
john.haltigan@camh.ca About Dr. John D. Haltigan
Dr. Hayley Hamilton
Senior Scientist, Institute for Mental Health Policy Research, CAMH
hayley.hamilton@camh.ca About Dr. Hayley Hamilton
CAMH receives first Canadian federal (CIHR) grant to study psilocybin
Researchers to explore whether psychedelic effect is required to treat depression
Read More
Probe of DNA repeats reveals genetic link to schizophrenia
A SickKids-CAMH study shows long repeated DNA sequences found in the genome may contribute to how the complex psychiatric disorder arises
Read More
From Research to Reality: Global Summit on Psychedelic-Assisted Therapies and Medicine
Bringing together policymakers, researchers and clinicians from around the world to discuss the state of research on psychedelic therapies and its translation to policy and practice.
Read More